Coronavirus Notebook: EU In More Vaccine Talks, HTA Rolling Reviews, and RECOVERY’s UK Expansion

 
• By Ian Schofield
  
Generate a summary of this article
Listen to this article
Beta

The European Commission is in talks to buy vaccines from CureVac and Moderna, amid concerns over “vaccine nationalism” and lack of transparency. Meanwhile the EU health technology assessment network has begun publishing “rolling collaborative reviews” of potential COVID-19 therapies, and two more firms have announced progress with monoclonal antibodies. 

COVID-19 vaccine ampules
Talks on purchasing COVID-19 vaccines are accelerating in the EU • Source: Shutterstock

EU efforts to secure a diversified portfolio of COVID-19 vaccines have taken another step forward after the European Commission confirmed it had completed exploratory talks with two more companies, CureVac BV and Moderna, Inc., for the purchase of potential vaccines against the SARS-CoV-2 virus. This brings to five the number of companies in vaccine talks with the EU.

The first set of discussions concerns CureVac’s mRNA-based vaccine. The proposed advance purchase agreement (APA) would provide for the initial...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By Saba Afreen

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     
    • By Anabel Costa-Ferreira and Ian Schofield

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography